Occult central nervous system involvement guides therapeutic choices in blastic plasmacytoid dendritic cell neoplasms

Leuk Lymphoma. 2022 Jul;63(7):1754-1757. doi: 10.1080/10428194.2022.2042687. Epub 2022 Mar 6.

Authors

Elisa Buzzatti^{1

2}, Giovangiacinto Paterno¹, Raffaele Palmieri^{1

2}, Fabiana Esposito^{1

2}, Maria Rosaria Pascale^{1

2}, Flavia Mallegni^{1

2}, Luca Guarnera^{1

2}, Gianmario Pasqualone^{1

2}, Maria Antonietta Irno Consalvo^{1

2}, Daniela Fraboni^{1

2}, Federico Moretti^{1

2}, Arianna Savi^{1

2}, Beatrice Borsellino³, Luca Maurillo², Francesco Buccisano^{1

2}, Giuseppe Sconocchia⁴, Adriano Venditti^{1

2}, Maria Ilaria Del Principe^{1

2}

Affiliations

¹ Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
² Fondazione Policlinico Tor Vergata, Rome, Italy.
³ Ancona University, Ancona, Italy.
⁴ Laboratory of Tumor Immunology and Immunotherapy, Institute of Translation Pharmacology, Department of Medicine, National Research Council of Italy (CNR), Rome, Italy.

PMID: 35253587
DOI: 10.1080/10428194.2022.2042687

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Central Nervous System
Dendritic Cells
Hematologic Neoplasms* / diagnosis
Hematologic Neoplasms* / therapy
Humans
Myeloproliferative Disorders*
Skin Neoplasms*